Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thierry VandenDriessche

Showing results (41-50 of 85) with videos related to

Pageof 9
Sort By:
Molecular Therapy. Nucleic Acids|March 13, 2020
Validation of miR-20a as a Tumor Suppressor Gene in Liver Carcinoma Using Hepatocyte-Specific Hyperactive piggyBac TransposonsJaitip Tipanee, Mario Di Matteo, Warut Tulalamba, et al.
Hepatology (Baltimore, Md.)|March 4, 2014
Treatment of phenylketonuria using minicircle-based naked-DNA gene transfer to murine liverHiu Man Viecelli, Richard P Harbottle, Suet Ping Wong, et al.
Genes|May 6, 2020
Genetic and Epigenetic Modification of Rat Liver Progenitor Cells via HNF4α Transduction and 5' Azacytidine Treatment: An Integrated miRNA and mRNA Expression Profile AnalysisJennifer Bolleyn, Matthias Rombaut, Nisha Nair, et al.
Nature Neuroscience|February 26, 2013
Low hippocampal PI(4,5)P₂ contributes to reduced cognition in old mice as a result of loss of MARCKSLaura Trovò, Tariq Ahmed, Zsuzsanna Callaerts-Vegh, et al.
Blood|February 16, 2006
Phenotypic correction of von Willebrand disease type 3 blood-derived endothelial cells with lentiviral vectors expressing von Willebrand factorSimon F De Meyer, Karen Vanhoorelbeke, Marinee K Chuah, et al.
Nature Protocols|June 5, 2015
Efficient derivation and inducible differentiation of expandable skeletal myogenic cells from human ES and patient-specific iPS cellsSara M Maffioletti, Mattia F M Gerli, Martina Ragazzi, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 17, 2008
Restoration of plasma von Willebrand factor deficiency is sufficient to correct thrombus formation after gene therapy for severe von Willebrand diseaseSimon F De Meyer, Nele Vandeputte, Inge Pareyn, et al.
Blood|May 22, 2009
A murine model for induction of long-term immunologic tolerance to factor VIII does not require persistent detectable levels of plasma factor VIII and involves contributions from Foxp3+ T regulatory cellsHideto Matsui, Masaru Shibata, Brian Brown, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 24, 2020
Towards a global multidisciplinary consensus framework on haemophilia gene therapy: Report of the 2nd World Federation of Haemophilia Gene Therapy Round TableGlenn F Pierce, K John Pasi, Donna Coffin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 19, 2014
Hyperactive piggyBac transposons for sustained and robust liver-targeted gene therapyMario Di Matteo, Emira Samara-Kuko, Natalie J Ward, et al.
Pageof 9

Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
Molecular Therapy. Nucleic Acids|March 13, 2020
Validation of miR-20a as a Tumor Suppressor Gene in Liver Carcinoma Using Hepatocyte-Specific Hyperactive piggyBac TransposonsJaitip Tipanee, Mario Di Matteo, Warut Tulalamba, et al.
Hepatology (Baltimore, Md.)|March 4, 2014
Treatment of phenylketonuria using minicircle-based naked-DNA gene transfer to murine liverHiu Man Viecelli, Richard P Harbottle, Suet Ping Wong, et al.
Genes|May 6, 2020
Genetic and Epigenetic Modification of Rat Liver Progenitor Cells via HNF4α Transduction and 5' Azacytidine Treatment: An Integrated miRNA and mRNA Expression Profile AnalysisJennifer Bolleyn, Matthias Rombaut, Nisha Nair, et al.
Nature Neuroscience|February 26, 2013
Low hippocampal PI(4,5)P₂ contributes to reduced cognition in old mice as a result of loss of MARCKSLaura Trovò, Tariq Ahmed, Zsuzsanna Callaerts-Vegh, et al.
Blood|February 16, 2006
Phenotypic correction of von Willebrand disease type 3 blood-derived endothelial cells with lentiviral vectors expressing von Willebrand factorSimon F De Meyer, Karen Vanhoorelbeke, Marinee K Chuah, et al.
Nature Protocols|June 5, 2015
Efficient derivation and inducible differentiation of expandable skeletal myogenic cells from human ES and patient-specific iPS cellsSara M Maffioletti, Mattia F M Gerli, Martina Ragazzi, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 17, 2008
Restoration of plasma von Willebrand factor deficiency is sufficient to correct thrombus formation after gene therapy for severe von Willebrand diseaseSimon F De Meyer, Nele Vandeputte, Inge Pareyn, et al.
Blood|May 22, 2009
A murine model for induction of long-term immunologic tolerance to factor VIII does not require persistent detectable levels of plasma factor VIII and involves contributions from Foxp3+ T regulatory cellsHideto Matsui, Masaru Shibata, Brian Brown, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 24, 2020
Towards a global multidisciplinary consensus framework on haemophilia gene therapy: Report of the 2nd World Federation of Haemophilia Gene Therapy Round TableGlenn F Pierce, K John Pasi, Donna Coffin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 19, 2014
Hyperactive piggyBac transposons for sustained and robust liver-targeted gene therapyMario Di Matteo, Emira Samara-Kuko, Natalie J Ward, et al.
Pageof 9